Dapagliflozin Patient Satisfaction Survey
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/17/2018 |
| Start Date: | June 22, 2016 |
| End Date: | October 29, 2018 |
Direct to Patient Survey to Examine Treatment Satisfaction and Experience With Dapagliflozin Compared to Sulfonylureas
The purpose of this study is to evaluate the diabetes related treatment satisfaction for
patients with type 2 diabetes mellitus
patients with type 2 diabetes mellitus
This is a cross-sectional, observational patient survey study. Study subjects will be adult
commercial members of the large US health plan affiliated with Optum with evidence of T2D
initiating dapagliflozin or a sulfonylurea medication within the 3 months prior to survey
mailing.
commercial members of the large US health plan affiliated with Optum with evidence of T2D
initiating dapagliflozin or a sulfonylurea medication within the 3 months prior to survey
mailing.
Inclusion Criteria:
- At least one pharmacy claim for dapagliflozin or dapagliflozin/metformin ER in the
most recent month of pharmacy data and no pharmacy claims for an SGLT2 medication
during the 6 months prior to sample identification.
- Evidence of T2D diagnosis.
- Age ≥18 as of the drug index date.
- 6 months of continuous enrollment in a commercial health plan with both pharmacy and
medical benefits during the identification period through the patient interview sample
identification date.
- Self-reported T2D diagnosis during the patient interview.
Exclusion Criteria:
- Patients with evidence of type 1 diabetes mellitus and unknown type
- Patients who are pregnant
We found this trial at
1
site
Click here to add this to my saved trials
